New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
Type 2 diabetes mellitus (T2 DM) is often seen in patients with obesity. Bariatric surgery, aimed to decrease body weight, can often help those patientsto improve glycemic status. After some of bariatric operations patients reach normoglycemia in few days, the fact that cant be explained onlyby redu...
Enregistré dans:
Auteur principal: | Ekaterina Alekseevna Shestakova |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/10b84ddc30fe49e8bc1951ad8ad7a583 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The associations of incretin hormone concentration with gestational diabetes mellitus
par: Tatiana V. Saprina, et autres
Publié: (2016) -
Incretins today: multiple effects and therapeutic potential
par: Oksana V. Tsygankova, et autres
Publié: (2019) -
The role of incretin-based therapies in the management of type 2 diabetes mellitus: perspectives on the past, present and future
par: Juris J. Meier
Publié: (2019) -
Vildagliptin: optimal control in type 2 diabetes mellitus treatment
par: Alexander Sergeevich Ametov
Publié: (2015) -
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect
par: Enrique Z. Fisman, et autres
Publié: (2021)